Announcement on Result of Shareholding Reduction by Shareholder
Filed with SSE · · 3 pages · Chinese
Zhejiang Shapuaisi Pharmaceutical Co. Ltd. on 6ix
Earlier from Zhejiang Shapuaisi Pharmaceutical
- Indicative Announcement on Change in Equity of Shareholders with Over 5% Shares Reaching 1% Scale
- Announcement on Resolutions of the 2nd Extraordinary General Meeting in 2025
- Announcement on Obtaining Notice of Approval for Drug Clinical Trial of Phenylephrine and Ketorolac Solution
- Indicative Announcement on Convening the 2nd Extraordinary General Meeting in 2025
- Announcement on Convening the Q3 2025 Performance Briefing
Later from Zhejiang Shapuaisi Pharmaceutical
- Announcement on Result of Shareholding Reduction by Shareholder through Call Auction
- Indicative Announcement on Expected Loss in Performance for 2025
- for Diflunisal Tablets
- Announcement on Expected Loss in Performance for 2025
- Announcement on Receiving Letter of Supervision and Inquiry Regarding Related-Party Asset Purchase of Zhejiang Shapuaisi Pharmaceutical Co., Ltd. from Shanghai Stock Exchange
Follow Zhejiang Shapuaisi Pharmaceutical into a list and get an email when it puts out news.
Follow Zhejiang Shapuaisi Pharmaceutical